Old Web
English
Sign In
Acemap
>
authorDetail
>
Megan M Disinski
Megan M Disinski
Immunology
Diffuse large B-cell lymphoma
Pathology
Mantle cell lymphoma
Refractory Mantle Cell Lymphoma
3
Papers
13
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase I/II study of a hybrid schedule of flavopiridol in relapsed/refractory mantle cell lymphoma (MCL) and diffuse large B-cell lymphoma (DLBCL)
2016
Journal of Clinical Oncology
Kevin Tay
Geoffrey I. Shapiro
Megan M Disinski
Lucian R. Chirieac
S. Pittaluga
Elaine S. Jaffe
John E. Janik
Adrian Wiestner
Wyndham H. Wilson
Kieron Dunleavy
Show All
Source
Cite
Save
Citations (7)
A Phase I/II Study of a Hybrid Schedule of Flavopiridol in Relapsed/Refractory Mantle Cell Lymphoma and Diffuse Large B-Cell Lymphoma
2010
Clinical Lymphoma, Myeloma & Leukemia
Kieron Dunleavy
Geoff Shapiro
Megan M Disinski
Lucian R. Chirieac
Stefania Pittaluga
Elaine S. Jaffe
John E. Janik
Adrian Wiestner
Wyndham H. Wilson
Show All
Source
Cite
Save
Citations (1)
NRF2 at the Interface of Oxidative and Endoplasmic Reticulum Stress Pathways Is a Critical Integrator of Bortezomib Response in Mantle Cell Lymphoma in Vitro and In Vivo.
2009
Blood
Marc A. Weniger
Edgar G. Rizzatti
Patricia Perez Galan
Delong Liu
Peter J. Munson
Nalini Raghavachari
Therese White
Megan M Disinski
Wyndham H. Wilson
Adrian Wiestner
Show All
Source
Cite
Save
Citations (5)
1